D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
OPRX holding history
OptimizeRx Corp in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OPRX overviewAll 13F holders of OPRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 138,084
- Value
- $789.8K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 138,084 | $789.8K | <0.1% | −4,839−3.4% | Reduced | Holders |
| Q1 2026 | 142,923 | $897.6K | <0.1% | +30,056+26.6% | Added | Holders |
| Q4 2025 | 112,867 | $1.38M | <0.1% | −208,184−64.8% | Reduced | Holders |
| Q3 2025 | 321,051 | $6.58M | <0.1% | −91,845−22.2% | Reduced | Holders |
| Q2 2025 | 412,896 | $5.57M | <0.1% | +62,977+18.0% | Added | Holders |
| Q1 2025 | 349,919 | $3.03M | <0.1% | +54,202+18.3% | Added | Holders |
| Q4 2024 | 295,717 | $1.44M | <0.1% | +32,062+12.2% | Added | Holders |
| Q3 2024 | 263,655 | $2.04M | <0.1% | −44,679−14.5% | Reduced | Holders |
| Q2 2024 | 308,334 | $3.08M | <0.1% | −40,558−11.6% | Reduced | Holders |
| Q1 2024 | 348,892 | $4.24M | <0.1% | −113,615−24.6% | Reduced | Holders |
| Q4 2023 | 462,507 | $6.62M | <0.1% | −137,886−23.0% | Reduced | Holders |
| Q3 2023 | 600,393 | $4.67M | <0.1% | +64,414+12.0% | Added | Holders |
| Q2 2023 | 535,979 | $7.66M | <0.1% | +64,747+13.7% | Added | Holders |
| Q1 2023 | 471,232 | $6.89M | <0.1% | +286,250+154.7% | Added | Holders |
| Q4 2022 | 184,982 | $3.11M | <0.1% | +100,553+119.1% | Added | Holders |
| Q3 2022 | 84,429 | $1.25M | <0.1% | +84,429 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −8,838−100.0% | Sold out | Holders |
| Q1 2021 | 8,838 | $431.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.